GOTELLI, EMANUELE
 Distribuzione geografica
Continente #
EU - Europa 4.862
NA - Nord America 1.771
AS - Asia 1.697
Continente sconosciuto - Info sul continente non disponibili 352
SA - Sud America 205
AF - Africa 38
OC - Oceania 1
Totale 8.926
Nazione #
IT - Italia 4.587
US - Stati Uniti d'America 1.676
SG - Singapore 616
CN - Cina 398
VN - Vietnam 298
BD - Bangladesh 180
BR - Brasile 137
FR - Francia 104
HK - Hong Kong 75
FI - Finlandia 51
CA - Canada 45
AR - Argentina 32
DE - Germania 28
ID - Indonesia 24
IN - India 23
JP - Giappone 23
MX - Messico 22
GB - Regno Unito 20
NL - Olanda 13
ZA - Sudafrica 13
CO - Colombia 11
AT - Austria 8
EC - Ecuador 8
JM - Giamaica 8
PH - Filippine 8
SE - Svezia 8
PY - Paraguay 7
RU - Federazione Russa 7
CL - Cile 6
TH - Thailandia 6
KE - Kenya 5
PL - Polonia 5
TR - Turchia 5
UZ - Uzbekistan 5
GT - Guatemala 4
HR - Croazia 4
KR - Corea 4
MA - Marocco 4
SC - Seychelles 4
TN - Tunisia 4
BE - Belgio 3
ES - Italia 3
IQ - Iraq 3
MY - Malesia 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BS - Bahamas 2
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UA - Ucraina 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LT - Lituania 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 8.575
Città #
Genoa 3.477
Vado Ligure 458
Singapore 300
St Louis 273
Genova 271
San Jose 237
Rapallo 209
Ashburn 127
Council Bluffs 105
Lauterbourg 92
Ho Chi Minh City 83
Hanoi 77
Hong Kong 72
New York 70
Beijing 67
Boardman 56
Los Angeles 44
Helsinki 41
Chicago 23
Milan 21
Santa Clara 21
Frankfurt am Main 16
Mexico City 16
Dallas 14
Haiphong 14
Bordighera 13
Da Nang 13
Rome 13
Tokyo 13
Houston 12
Atlanta 11
Buffalo 10
Lappeenranta 10
Jamaica Plain 9
Las Vegas 9
Montreal 9
Orem 9
Padua 9
São Paulo 9
Vienna 9
Waltham 9
Medford 8
Philadelphia 8
Washington 8
Amsterdam 7
Biên Hòa 7
Kingston 7
Naples 7
Phoenix 7
Salt Lake City 7
Denver 6
Miami 6
Bắc Giang 5
Gwynn Oak 5
Hải Dương 5
Paris 5
San Francisco 5
Seattle 5
Stockholm 5
Tashkent 5
Thái Bình 5
Tianjin 5
Baltimore 4
Bangkok 4
Bengaluru 4
Bologna 4
Boston 4
Brasília 4
Can Tho 4
Cape Town 4
Curitiba 4
Fayetteville 4
Guatemala City 4
Jakarta 4
Johannesburg 4
Mumbai 4
Nairobi 4
Queens 4
Rochester 4
The Bronx 4
Thái Nguyên 4
Toronto 4
Tulsa 4
Warsaw 4
Zagreb 4
Asunción 3
Baghdad 3
Bogotá 3
Buenos Aires 3
Bắc Ninh 3
Chennai 3
City of London 3
Columbia 3
Columbus 3
Detroit 3
Dhaka 3
Elk Grove Village 3
Fort Myers 3
Glasgow 3
Hangzhou 3
Totale 6.616
Nome #
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases 177
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 147
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 143
CHARACTERIZATION OF MONOCYTE/MACROPHAGE CELL POPULATIONS IN PERIPHERAL BLOOD AND IN THE LUNG TISSUE OF SYSTEMIC SCLEROSIS PATIENTS 139
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 131
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 129
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 128
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 128
The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases 127
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms 126
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 125
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 121
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 119
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 118
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 118
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 114
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography 112
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 111
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study 109
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 105
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients 105
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update 104
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update 102
Microvascular status and skin thickness in adults with hypermobile Ehlers-Danlos syndrome: a pilot investigation 102
Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. 102
AB0354 FDG-PET-DETECTED LARGE VESSEL VASCULITIS DOES NOT PREDICT DISEASE OUTCOME IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA 100
POS1087 Heart involvement evaluation by speckle-tracking global longitudinal strain as further predictor of organ damage in Systemic Sclerosis according to microvascular status 97
Immune system activation in polymyalgia rheumatica: Which balance between autoinflammation and autoimmunity? A systematic review 95
Vitamin D and Muscle Status in Inflammatory and Autoimmune Rheumatic Diseases: An Update 93
POS0394 AMINAPHTONE SHORT-TERM TREATMENT REDUCES TGF-BETA PLASMA LEVELS IN SYSTEMIC SCLEROSIS PATIENTS WITH SECONDARY RAYNAUD’S PHENOMENON 92
Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud's phenomenon: a detailed capillaroscopic analysis. 91
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. 91
AB0438 SERUM HOMOCYSTEINE AND BONE STATUS IN SYSTEMIC SCLEROSIS PATIENTS 91
Vitamin D and Lung Outcomes in Elderly COVID-19 Patients 90
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study 89
POS0645 NAILFOLD VIDEOCAPILLAROSCOPY AS MARKER OF MICROVASCULAR STATUS IN RHEUMATOID ARTRITIS MAY ALSO IDENTIFY THE CONCOMITANT PRESENCE OF OVERLAP SYNDROMES 87
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients. 85
Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis. 84
AB0080 IMBALANCE OF MONOCYTE/MACROPHAGE POLARIZATION IN PERIPHERAL BLOOD AND SYNOVIAL FLUID OF RHEUMATOID ARTHRITIS PATIENTS 83
AB0092 CTLA4-Ig PROMOTES THE M1-M2 SHIFT IN CULTURED MACROPHAGES OF RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE: IN VITRO STUDY 81
AB0374 LUPUS LOW DISEASE ACTIVITY STATE AND MAINTAINING DRUG THERAPY: A RETROSPECTIVE INVESTIGATION 80
POS0132 POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS INDUCED BY IMMUNE CHECKPOINT INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS REVEALING KEY DIFFERENCES WITH THE IDIOPATHIC FORMS 80
AB1160 IMPACT OF COVID-19 TREATMENTS ON PERIPHERAL CAPILLARY DENSITY EVALUATED BY NAILFOLD VIDEOCAPILLAROSCOPY 79
POS0568 Progressive microvascular abnormalities detectable overtime by nailfold videocapillaroscopy in long-COVID patients: a multicenter Italian investigation 79
Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging 78
AB0578 LONG-TERM TOLERABILITY OF AMINAPHTONE IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS IN CONCOMITANT STANDARD THERAPY 78
The dichotomy of glucocorticosteroid treatment in immuneinflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice 78
Microvascular status in juvenile Sjögren's disease: the first nailfold videocapillaroscopy investigation 77
POS1250 VITAMIN D DEFICIENCY IS MAINLY ASSOCIATED WITH SEVERE LUNG INVOLVEMENT, LONGER DISEASE DURATION AND RISK OF DEATH IN ELDERLY COVID-19 PATIENTS 76
Differences in nailfold capillaroscopy findings between limited and diffuse cutaneous systemic sclerosis: a detailed analysis 75
AB1210 FIBROMYALGIA AND BODY MASS COMPOSITION IN POST-MENOPAUSAL WOMEN: PRELIMINARY RESULTS FROM A CROSS-SECTIONAL MONOCENTRIC STUDY 75
POS1337 CLINICAL OUTCOMES OF METHOTREXATE TREATMENT FOR IMMUNE CHECKPOINT INHIBITOR-INDUCED ARTHRITIS IN CANCER PATIENTS: A RETROSPECTIVE LONGITUDINAL PILOT STUDY 75
FRI0257 CAPILLAROSCOPIC VERY EARLY MORPHOLOGICAL AND QUANTITATIVE SPECIFIC ABNORMALITIES ANTICIPATE THE DEVELOPMENT OF THE “SCLERODERMA PATTERN” IN PATIENTS WITH RAYNAUD'S PHENOMENON 73
POS0862 NAILFOLD CAPILLAROSCOPY IN UNDIFFERENTIATED AND MIXED CONNECTIVE TISSUE DISEASES 73
Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors 73
AB1187 LONG-TERM SAFETY AND EFFICACY OF AMINAPHTONE IN SYSTEMIC SCLEROSIS PATIENTS WITH ACTIVE RAYNAUD’S PHENOMENON 72
AB0057 IN VITRO EFFECT OF CTLA4-IGG ON M1-M2 SHIFT OF MACROPHAGES FROM RHEUMATOID ARTHRITIS PATIENTS 72
AB0168 NINTEDANIB (TYROSINE-KINASE INHIBITOR) INHIBITS THE TRANSITION OF CIRCULATING FIBROCYTES ISOLATED FROM SYSTEMIC SCLEROSIS PATIENTS INTO MYOFIBROBLASTS: AN IN VITROSTUDY 72
ABS0404 DIFFERENCES IN NAILFOLD VIDEOCAPILLAROSCOPY ANALYSIS COMPARING LIMITED CUTANEOUS AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A DETAILED, RETROSPECTIVE STUDY 72
AB0408 DOES THE PRESENCE IN THE SERUM OF ANTIPHOSPHOLIPID ANTIBODIES CORRELATE WITH SPECIFIC/NON SPECIFIC CAPILLAROSCOPIC ABNORMALITIES? 72
AB0330 ANTIPHOSPHOLIPID ANTIBODIES AND ANTICOAGULANT TREATMENT: CAPILLAROSCOPIC FINDINGS 68
The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. 67
SAT0337 EVALUATION OF BODY COMPOSITION AND BONE STATUS ACCORDING TO MICROVASCULAR INVOLVEMENT IN SYSTEMIC SCLEROSIS PATIENTS 67
Influence of Seasonal Vitamin D Changes on Clinical Manifestations of Rheumatoid Arthritis and Systemic Sclerosis 67
AB0276 NAILFOLD VIDEO CAPILLAROSCOPY SUPPORT THE DIAGNOSIS OF OVERLAP CONNECTIVE TISSUE DISEASE: A PILOT STUDY IN A SAMPLE OF RHEUMATOID ARTHRITIS PATIENTS 66
AB1437 NAILFOLD CAPILLAROSCOPY IN DEFICIENCY OF ADENOSINE DEAMINASE 2 (DADA2): A CASE-CONTROL STUDY 66
An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study 65
Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patients 65
POS1417 CHOROIDAL THICKNESS AS A NOVEL IMAGING MICROVASCULAR BIOMARKER FOR DISEASE PHENOTYPE IN SYSTEMIC SCLEROSIS: INSIGHTS FROM OCTA, LASCA AND NVC ANALYSES 65
AB0845 INVESTIGATING PERIPHERAL MICROCIRCULATION IN JUVENILE SJÖGREN’S SYNDROME: A PILOT STUDY USING NAILFOLD VIDEOCAPILLAROSCOPY 64
AB0738 Do cosmetic silicone implants trigger systemic sclerosis? | Annals of the Rheumatic Diseases 64
Clinical outcomes in cancer patients with immune checkpoint inhibitor-induced arthritis treated with methotrexate: a retrospective longitudinal monocentric pilot study 64
AB0739 Aminaphtone tolerability and safety in scleroderma patients: a four-year follow-up | Annals of the Rheumatic Diseases 64
THU0359 GENDER IMPACT ON LOWER URINARY TRACT INVOLVEMENT IN SYSTEMIC SCLEROSIS PATIENTS 64
Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 64
Temporomandibular disorders in immune-mediated rheumatic diseases of the adult: A systematic review 64
POS0962 ENGINEERED GLOVE FOR THE OBJECTIVE ASSESSMENT OF HAND DEXTERITY IN SYSTEMIC SCLEROSIS PATIENTS 62
Mapping in healthy subjects different body areas for dermal thickness and skin hardness by high frequency ultrasound and durometry 62
SAT0300 SERUM FROM “EARLY” SYSTEMIC SCLEROSIS PATIENTS ALREADY INDUCES THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE (M2) IN CULTURED HUMAN MONOCYTES 61
AB1310 UTILIZATION AND ATTITUDES TOWARDS NAILFOLD VIDEOCAPILLAROSCOPY FOR THE ASSESSMENT OF MICROVASCULAR STATUS IN PATIENTS WITH LONG-COVID: A MULTICENTER ONLINE SURVEY 61
AB1351 FULL LONGITUDINAL NAILFOLD VIDEOCAPILLAROSCOPY ANALYSIS OF MICROVASCULAR CHANGES DURING NORMAL PREGNANCY 60
Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19 60
AB0805 DESCRIPTION IN FLOW IN EARLY VERSUS CLINICALLY OVERT SYSTEMIC SCLEROSIS. LASER SPECKLE CONTRAST ANALYSIS: A DESCRIPTIVE STUDY ON THE PERIPHERAL BLOOD OF THE DIFFERENT SUBTYPES OF SYSTEMIC SCLEROSIS 59
AB1564 PERIPHERAL BLOOD PERFUSION IN MCTD AND UCTD PATIENTS: A CROSS-SECTIONAL MONOCENTRIC STUDY 57
Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause 57
AB0679 NAILFOLD VIDEOCAPILLAROSCOPY RESULTS IN COVID-19 PATIENTS RECOVERED FROM DIFFERENT DISEASE SEVERITY 57
A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered ‘early’? 55
POS1488-HPR NAILFOLD VIDEOCAPILLAROSCOPY IN JUVENILE DERMATOMYOSITIS: CORRELATIONS BETWEEN MICROVASCULAR ABNORMALITIES AND CLINICAL FEATURES 54
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study 53
The importance of neuroendocrine immunology pathways in course of COVID-19 51
Glucocorticoids in rheumatoid arthritis still on first line: the reasons. 51
Immune-modulatory effects of low oestrogen serum concentrations on the progression of ACPA-negative inflammatory arthritis in postmenopause 51
POS0815 ULTRASONOGRAPHY FOR DAY-TO-DAY CLINICAL USE: CONSTRUCTION OF A SIMPLE DISCRIMINATOR BETWEEN HEALTHY SKIN AND THICKENED SYSTEMIC SCLEROSIS SKIN 51
POS0882 AMINAPHTONE LONG-TERM TREATMENT IN SYSTEMIC SCLEROSIS 51
Endogenous and exogenous environmental hormone D (vitamin D) suppliers in autoimmune rheumatic diseases 50
Description of Peripheral Blood Perfusion by Laser Speckle Contrast Analysis (LASCA) in ‘Early’ versus ‘Clinically Overt’ Systemic Sclerosis in Routine Clinics 49
POS0850 NAILFOLD CAPILLARY DILATIONS IN RAYNAUD'S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN‘ 49
Updating on pregnancy in rheumatoid arthritis 48
POS1237 MICROVASCULAR DAMAGE IN AUTOIMMUNE CONNECTIVE TISSUE DISEASES: A CAPILLAROSCOPIC ANALYSIS FROM 20 YEARS OF EXPERIENCE IN A EULAR TRAINING AND RESEARCH REFERRAL CENTER FOR IMAGING 48
Understanding the immune-endocrine effects of vitamin D in SARS- CoV-2 infection: a role in protecting against neurodamage? 47
Totale 8.248
Categoria #
all - tutte 29.673
article - articoli 28.981
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 344
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022168 3 13 0 9 10 3 26 30 22 16 12 24
2022/2023277 30 27 5 11 42 29 11 21 38 16 42 5
2023/2024412 21 46 5 53 22 51 22 48 9 19 28 88
2024/20251.329 80 82 59 82 134 108 126 204 40 166 129 119
2025/20266.147 542 424 628 1.114 554 355 588 233 440 657 305 307
2026/2027461 461 0 0 0 0 0 0 0 0 0 0 0
Totale 8.926